At this time, Semler Scientific announced it has elevated its Bitcoin holdings. The corporate acquired 185 Bitcoin between Could 23 and June 3 for $20 million with a median buy value of $107,974 per Bitcoin, utilizing proceeds from its at-the-market (ATM) providing program.
“We proceed to accretively develop our bitcoin arsenal utilizing working money circulate and proceeds from debt and fairness financings,” mentioned the chairman of Semler Scientific Eric Semler. “And we’re excited to launch the Semler Scientific dashboard immediately on our web site to supply the general public with frequently up to date data on our bitcoin holdings and different key metrics.”
Since launching the ATM program in April 2025, Semler has raised roughly $136.2 million below the gross sales settlement of over 3.6 million shares of its frequent inventory.
As of June 3, 2025, Semler holds 4,449 Bitcoin which have been acquired for an quantity of $410.0 million, with a median buy value of $92,158 per Bitcoin. On the time of writing, the market worth of those holdings is round $446.2 million.
Eric Semler on X posted, “SMLR acquires 185 Bitcoins for $20 million and has generated BTC Yield of 26.7% YTD. Now holding 4,449 $BTC.”
Semler Scientific makes use of the BTC Yield as a key efficiency indicator (KPI) to assist assess the efficiency of its technique of buying Bitcoin. As of year-to-date, the corporate has achieved a BTC Yield of 26.7%.
“Semler Scientific believes this KPI can be utilized to complement an investor’s understanding of Semler Scientific’s determination to fund the acquisition of Bitcoin by issuing extra shares of its frequent inventory or devices convertible to frequent inventory,” said the 8-Ok kind.
In Q1 FY2025, Semler Scientific reported a tough quarter. Income got here in at $8.8 million, a 44% lower year-over-year. Working bills jumped to $39.9 million from $8.9 million final yr, primarily attributable to a $29.8 million contingent legal responsibility tied to the potential settlement with the DOJ. This led to a $31.1 million working loss, in comparison with a $7.0 million revenue in Q1 2024.
“Our healthcare enterprise is seeing inexperienced shoots from the cardiovascular product line that we launched to our giant enterprise buyer base this yr,” mentioned the CEO of Semler Scientific Doug Murphy-Chutorian. “We predict development and money technology from these FDA-cleared services, which is able to add to our bitcoin treasury technique.”
The content published on Finance Insider Today is for informational and educational purposes only. It does not constitute financial advice, investment advice, or any other form of professional advice. Always conduct your own research and consult a qualified financial advisor before making any investment decisions. Finance Insider Today is not responsible for any financial losses resulting from decisions made based on information published on this website. Past performance is not indicative of future results. Financial markets carry significant risk. Never invest more than you can afford to lose.
